Andrew Huberman· PhD
It is actually a schedule two drug in the United States, which means that it has a very, very limited yet still present medical application, mainly as an anesthetic in certain laboratory and hospital conditions.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
It is actually a schedule two drug in the United States, which means that it has a very, very limited yet still present medical application, mainly as an anesthetic in certain laboratory and hospital conditions.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.